title: C-type natriuretic peptide plasma levels are reduced in obese adolescents.
abstract: The high prevalence of obesity in children may increase the magnitude of lifetime risk of cardiovascular disease (CD). At present, explicit data for recommending biomarkers as routine pre-clinical markers of CD in children are lacking. C-type natriuretic peptide (CNP) is assuming increasing importance in CD; in adults with heart failure, its plasma levels are related to clinical and functional disease severity. We have previously reported five different reference intervals for blood CNP as a function of age in healthy children; however, data on plasma CNP levels in obese children are still lacking. Aim of this study was to assess CNP levels in obese adolescents and verify whether they differ from healthy subjects. Plasma CNP was measured in 29 obese adolescents (age: 11.8 ± 0.4 years; BMI: 29.8 ± 0.82) by radioimmunoassay and compared with the reference values of healthy subjects. BNP was also measured. Both plasma CNP and BNP levels were significantly lower in the obese adolescents compared to the appropriate reference values (CNP: 3.4 ± 0.2 vs 13.6 ± 2.3 pg/ml, p<0.0001; BNP: 18.8 ± 2.6 vs 36.9 ± 5.5 pg/ml, p=0.003). There was no significant difference between CNP values in males and females. As reported in adults, we observed lower plasma CNP and BNP levels in obese children, suggesting a defective natriuretic peptide system in these patients. An altered regulation of production, clearance and function of natriuretic peptides, already operating in obese adolescents, may possibly contribute to the future development of CD. Thus, the availability of drugs promoting the action of natriuretic peptides may represent an attractive therapeutic option to prevent CD.
authors.affiliation: CNR Institute of Clinical Physiology, CNR, Italy. Electronic address: delry@ifc.cnr.it.
authors.forename: S
authors.initials: S
authors.lastname: Del Ry
authors.forename: M
authors.initials: M
authors.lastname: Cabiati
authors.forename: V
authors.initials: V
authors.lastname: Bianchi
authors.forename: S
authors.initials: S
authors.lastname: Storti
authors.forename: C
authors.initials: C
authors.lastname: Caselli
authors.forename: T
authors.initials: T
authors.lastname: Prescimone
authors.forename: A
authors.initials: A
authors.lastname: Clerico
authors.forename: G
authors.initials: G
authors.lastname: Saggese
authors.forename: D
authors.initials: D
authors.lastname: Giannessi
authors.forename: G
authors.initials: G
authors.lastname: Federico
mesh_terms: D000293:Adolescent; D000328:Adult; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control; D002648:Child; D005260:Female; D006801:Humans; D008297:Male; D020097:Natriuretic Peptide, Brain / Q000097:blood*; D020098:Natriuretic Peptide, C-Type / Q000097:blood*; D009765:Obesity / Q000097:blood* / Q000150:complications; D011863:Radioimmunoassay; D012016:Reference Values
chemical_list: D020097:Natriuretic Peptide, Brain; D020098:Natriuretic Peptide, C-Type
keywords: Adolescents; C-type natriuretic peptide; Natriuretic peptides; Obesity